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Given the lack of information 
concerning the role of Chlamydia 
trachomatis in male infertility, it has 
become imperative to analyse the 
quality of semen of male with 
seroevidence of antibody to Chlamydia 
trachomatis infection. A total of 156 
male patients attending the Human 
Reproduction Research Programme/ 
Invitro Fertililzation Centre of 
University of Benin Teaching Hospital 
(UBTH) Benin City, Edo state were 
enrolled into this study. Standard 
semen analysis and serological 
investigation of Chlamydia trachomatis 
were done for each male patient 
according to the laboratory diagnosis 
of sexually transmitted diseases of 
WHO (1999). Chlamydia trachomatis 
antibody was found to be Seropositive 
in 37(24%) male patients. Standard 
semen analysis showed abnormality in 
the various semen parameters of the 
seropositive male patients. The 
Seminal fluid analysis of the 
Seropositive male patients had total 
average mean sperm morphology of 
11.0% (normal), total sperm count 
(10.0×106) ml, motility (11.0%) vitality 
(17.0%) (live) and leucocyte count 
1.5×106 ml lower than the average 
mean sperm morphology of 28.0%, 
vitality 63%, total sperm count 
(30.5×106ml), motility  (61.0%) and 
leucocyte count (0.5×106ml) of the 28 
age-matched male subject used as 
control (P<0.05). This study indicates 
that Chlamydia trachomatis may be an 
independent risk factor affecting 
semen quality of male and 
consequently infertility. 
Key words: Serology, Chlamydia 
trachomatis, sperm quality.    
 
INTRODUCTION  
Chlamydia trachomatis infection 
is the most prevalent sexually 
transmitted bacterial infection 
throughout the world1. While some 
authors are convinced that Chlamydia 
infections in male can lead to serious 
problems while others are less certain 
and have argued that its effects on 
female reproduction are far more 
important with far reaching 
consequences2. 
In an attempt to link Chlamydia 
infection in male with reproductive 
problems, a number of studies have 
investigated the relationship between 
the infection and semen quality. 
However, some studies have shown 
that infection is associated with poorer 
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semen quality while others have 
claimed that it is not3. Another school 
of thought believed that Chlamydia 
trachomatis infection may influence 
infertility by inducing sperm 
autoantibodies or by impairing more 
subtle aspects of sperm quality not 
registered by conventional 
techniques4,5. Furthermore, increased 
incidence of Chlamydia trachomatis 
has been found in male with 
obstructive azoospermia4. Unlike IgG, 
IgA is an immunoglobulin which is 
secreted locally in response to 
relatively more recent infection. A 
study has reported elevated levels of 
IgA in the seminal plasma of 27% of 
male patient with reproductive problem 
or sub fertility3.  
More recently, authors have 
measured Chlamydia specific 
immunoglobulin either in serum or 
seminal plasma, One of them measure 
Chlamydia specific serum IgG in 50% 
sub fertile male group with a previous 
genital infection6. This has led to 
confusion in the literature, but in 
reality, the studies are frequently not 
comparable because of different, and 
inadequate, diagnostic methods and 
test specimens used to identify those 
male with Chlamydia infection. For 
example, a number of studies have 
based their diagnosis on an attempt to 
culture Chlamydia trachomatis from 
ejaculates or urethral swabs however; 
seminal plasma is known to be 
inhibitory to the effective culture of 
Chlamydia trachomatis6. Other studies 
have attempted to overcome these 
problems by attempting to use 
serological method although the 
detection of serum antibodies of 
Chlamydia trachomatis in 
asymptomatic male is not particularly 
helpful5. Moreover, because the 
immune response differs between 
individuals, it is not always clear 
whether a single elevated antibody 
titer represents an active or current 
infection to which a strong immune 
response was generated. In this 
situation, all that can be said is that the 
detection of antibody to Chlamydia 
trachomatis in the serum or seminal 
plasma of men is suggestive current or 
active Chlamydia trachomatis 
infection.  
This study attempts to 
determine the Seroprevalence of 
Chlamydia trachomatis infection and 
its association with semen quality of 
male undergoing Assisted 
Reproduction Technology (ART) 
 
MATERIALS AND METHODS 
A total of 156 male patients 
were recruited or enrolled in this study 
with 28 age-matched male with 
normozoospemia used as control. All 
the male patients were undergoing 
semen analysis as part of the 
mandatory work-up for infertility 
investigation for possible Assisted 
Reproduction Technology/ Invitro 
Fertilization Programme after failing to 
conceive with their partner after at 
least 1 to 2 years of marriage and 
unprotected sexual exposure. None of 
the male patient reported any 
symptoms of genitourinary infections 
and was therefore considered 
asymptomatic of Sexually Transmitted 
Diseases. There was no age restriction 
and structured questionnaire were 
distributed to ascertain their social 
demographic history. 
Seminal fluid analysis: Prior to 
semen analysis, the male patients 
were provided with written information 
and were asked to abstain from sexual 
intercourse for 3-5days before the 
seminal fluid analysis. All samples for 
analysis were produced on site 
through masturbation or coitus 
interruptus and collected into standard 
containers that had previously been 
shown not to have any cytotoxic 
effects on human spermatozoa 
according to the methods outlined in 
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World Health Organizations (WHO 
1999). The semen was allowed to stay 
for up to 30 minutes to liquefy at 37oC 
before the analysis. Semen analysis 
was performed according to WHO 
(1999) guidelines with all the 
measures of semen quality parameters 
i.e. Sperm morphology, sperm motility, 
sperm vitality, concentration and 
leucocyte enumeration. Eosin-
Negrosin and Papanicolaou stains 
were used to performed sperm 
morphology and vitality tests 
respectively according to WHO (1999) 
criteria. 
The laboratory employed a 
comprehensive internal quality control 
programme for semen analysis based 
on World Health Organization’s 10th 
Semenology and Cervical Cytology 
workshop 2008.  
Seroanalysis of Chlamydia 
trachomatis: 4mls of Blood sample 
was collected from each male patient 
by trained phlebotomist the blood was 
allowed to clot to aspirate the serum 
for the serodetection of the antibody to 
Chlamydia trachomatis using the 
Immunocomb Chlamydia trachomatis 
IgG test which is an indirect solid 
phases Enzyme Immuno Absorbent 
(EIA) in line with WHO 1999 guidelines 
for the laboratory diagnosis of 
Chlamydia trachomatis infection with a 
performance characteristic of 95% 
sensitivity and 90% specificity. The 
serodiagnostic kit used was produced 
by organic Product France 
 
RESULT 
The 37 (24%) of the 156 male patients 
investigated in this study were found to 
be seropositive for the antibody to 
Chlamydia trachomatis with only 1(3%) 
of the 31 age-matched controls 
showed seropositivity (Table I). The 
data obtained in this study were 
analysed using the statistical package 
for social sciences SPSS version 10.0 
statistical software. Increase mean 
leucocytes counts were obtained in 
semen from seropositive male patients 
in this study. The corresponding 
standard semen analysis carried out 
on the male patients recruited in this 
study showed abnormal counts in 
Sperm motility, concentration, 
morphology, vitality in the investigated 
seropositive male patients and the 
mean values of the semen parameters 
were lower than the mean values of 
semen parameters obtain in the 
control subjects (P<0.05) . 
(Table II)  
 
Table I: AGE CLASSIFICATION OF INFERTILE MALE PATIENTS AND 
CONTROLS WITH SEROPOSITIVE CHLAMYDIA INFECTION  
 INFERTILE SUBJECTS CONTROLS 
Age (yrs) No. Examined No positive 
(%) 
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Table II: MEAN SEMEN QUALITY OF SEROPOSITIVE INFERTILE MALE 
PATIENTS AND CONTROLS 
 SEROPOSITIVE CONTROLS 
Age 
(Yrs) 
Tm Mor. Vit. Tc. Leu. Tm Mor. Vit. Tc. Leu. 
20-24 10 8 20 8.6 1.2 60 30 65 32 0.5 x 
106 
25-29 10 10 15 11.2 2.4 50 29 69 28 0.4 
30-34 14 8 21 8.4 1.8 50 25 70 35 0.6 
35-39 9 12 15 10.0 1.5 48 30 66 28 0.3 
40-44 15 16 20 9.6 1.7 51 29 72 31 0.9 
>45 10 10 12 12.4 1.4 50 30 67 28 0.4 
Total 
Average 
11 11 17 10 1.5 61 28 63 30 0.5 
Keys:      W.H.O CRITERIA 1999 
Tm-Total Motility in %   >50% 
Mor-Morphology in %   >30% 
Vit-Vitality in %   >75 %( Live) 
Tc- Total sperm count ×106/ml  >20million/ml 
Leu-Leucocytes count×106/ml <1.0million/ml 
 
DISCUSSION 
In this study, 37 (24%) of 156 male 
patients that attended Human 
Reproduction Research Programme/ 
Invitro fertilization centre of the 
hospital were found to be seropositive 
for Chlamydia trachomatis antibody. 
The seroprevalence rate of 24% 
obtained in this study is similar to the 
27% recorded among subfertile male 
group in previous studies7. Recently, 
some authors detected Chlamydia 
specific immunoglobulin in serum or 
seminal plasma of infertile male 
patients. One of them detected 
Chlamydia specific serum IgG in 50% 
subfertile male group with a previous 
genital infection4,7. Unlike IgG, IgA is 
an immunoglobulin which is secreted 
locally in response to relatively more 
recent infection3,8,9.  
The seminal fluid analysis obtained 
among the seropositive infertile male 
subjects in this study showed 
abnormalities and decrease count in 
almost all the semen parameters 
which further explained the 
pathological significance of Chlamydia 
trachomatis in the upper genital tract of 
male leading to the presence of both 
white blood cells, dead sperm and 
antichlamydia antibodies in semen10 
Furthermore, increased incidence of 
Chlamydia trachomatis has been 
found in male with obstructive 
azoospermia1,9. Chlamydia 
trachomatis infection induces      
leucoctytocspermia leading to elevated 
leucocytes-derive reactive oxygen 
species which damages sperm by 
causing peroxidation, decrease sperm 
numbers and impaired sperm 
motility6,10.  
In this situation, all that can be 
said is that the detection of antibody to 
Chlamydia trachomatis in the serum or 
seminal plasma of men is suggestive 
current or active Chlamydia 
trachomatis infection. Furthermore, 
increased incidence of Chlamydia 
trachomatis has been found in male 
with obstructive azoospermia4.   
 
CONCLUSION  
This study supported the initial 
hypothesis which state that the 
ejaculate of male whose serum were 
seropositive for the Chlamydia 
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trachomatis antibody would be more 
likely to contain dead sperms and 
therefore would more likely be 
asthenozoospermic or 
necrozoospermic. 
It is hereby recommended based on 
the findings from this study that 
seminal plasma or serum of infertile 
male patients and their female 
partners attending fertility clinic should 
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